Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa

Autor: Nalado AM, Mahlangu JN, Waziri B, Duarte R, Paget G, Olorunfemi G, Naicker S

Publikováno v: International Journal of Nephrology and Renovascular Disease, Vol Volume 12, Pp 19-32 (2019)

Aishatu Mohammed Nalado,1,2 Johnny N Mahlangu,3 Bala Waziri,1 Raquel Duarte,1 Graham Paget,1 Gbenga Olorunfemi,4 Saraladevi Naicker1 1Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Science, University of the Witwaters

Externí odkaz: https://doaj.org/article/93d7181995d248309644a62597c370a6

Requirements to participate in haemophilia clinical trials.

Autor: Mahlangu JN; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Parktown, South Africa.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Apr; Vol. 26 Suppl 3, pp. 22-25.

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies.

Autor: Chowdary P; Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital London UK., Holmström M; Coagulation Unit, Department of Hematology, Department of Medicine, Karolinska Institute Solna Karolinska University Hospital Stockholm Sweden.; Department of Health, Medicine and Caring Sciences Linköping University Linköping Sweden., Mahlangu JN; Hemophilia Comprehensive Care Centre, Department of Molecular Medicine and Haematology, Faculty of Health Sciences University of the Witwatersrand and National Health Laboratory Service Johannesburg South Africa., Ozelo MC; Hemocentro UNICAMP University of Campinas São Paulo Brazil., Pabinger I; Clinical Division of Hematology and Hemostaseology, Department of Medicine I Medical University of Vienna Vienna Austria., Pasi KJ; Royal London Hospital Haemophilia Centre Barts and The London School of Medicine and Dentistry London UK., Ragni MV; Division of Hematology/Oncology, and Hemophilia Center of Western PA, Department of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA., Shapiro A; Indiana Hemophilia and Thrombosis Center Indianapolis Indiana USA., Barnowski C; Sanofi Waltham Massachusetts USA., Lethagen S; Swedish Orphan Biovitrum AB Stockholm Sweden.; Copenhagen University Copenhagen Denmark.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2022 Jul 26; Vol. 6 (5), pp. e12760. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH.

Autor: van Galen KPM; Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., d'Oiron R; Centre de Référence de l'Hémophilie et des Maladies Hémorragiques Constitutionnelles, APHP Paris Saclay - Hôpital Bicêtre and Inserm U 1176, Le Kremlin Bicêtre, France., James P; Department of Medicine, Queen's University, Kingston, Ontario, Canada., Abdul-Kadir R; Department of Obstetrics and Gynaecology and Katharine Dormandy Haemophilia and Thrombosis Unit, The Royal Free Foundation Hospital and Institute for Women's Health, University College London, London, UK., Kouides PA; University of Rochester, Rochester, New York, USA.; The Mary M. Gooley Hemophilia Center, Rochester, New York, USA., Kulkarni R; Michigan State University, East Lansing, Michigan, USA., Mahlangu JN; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Othman M; School of Medicine, Queen's University, and School of Baccalaureate Nursing, St. Lawrence College, Kingston, Ontario, Canada., Peyvandi F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Rotellini D; National Hemophilia Foundation, Gibsonia, Pennsylvania, USA., Winikoff R; Department of Pediatric, Service of Hematology, Sainte-Justine Hospital, Montreal, Quebec, Canada., Sidonio RF; Aflac Cancer and Blood Disorders, Emory University, Decatur, Georgia, USA.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Aug; Vol. 19 (8), pp. 1883-1887.

Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.

Autor: Oldenburg J; Department of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany., Tran H; The Alfred Hospital, Melbourne, Vic., Australia., Peyvandi F; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Fondazione Ca, Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Núñez R; Hospital Universitario Virgen Del Rocio, Seville, Spain., Trask P; Genentech, Inc., South San Francisco, CA, USA., Chebon S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Mahlangu JN; Haemophilia Comprehensive Care Centre, Faculty of Health Sciences, University of the Witwatersrand and NHLS, Johannesburg, South Africa., Lehle M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Jiménez-Yuste V; La Paz University Hospital, Autónoma University, Madrid, Spain., von Mackensen S; Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 May; Vol. 27 (3), pp. 398-407. Date of Electronic Publication: 2021 Feb 12.